Showing results (21-30 of 312) with videos related to
Sort By:
Pageof 32
European Journal of Medical Research|July 2, 2011
Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a German multicenter trialMarcus Schlemmer, S Bauer, R Schütte, et al.Oncology|July 15, 1998
Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II studyJ T Hartmann, C H Köhne, H J Schmoll, et al.European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver metastasesJ T Hartmann, E Schmoll, C Bokemeyer, et al.Investigational New Drugs|July 27, 2012
A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancerJ T Hartmann, C Kollmannsberger, I Cascorbi, et al.Anti-Cancer Drugs|April 11, 2000
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumorsJ T Hartmann, S Knop, L M Fels, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2009
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumorsA Lorch, A Neubauer, M Hackenthal, et al.Investigational New Drugs|September 1, 2005
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcomaJ T Hartmann, K Oechsle, J Huober, et al.Seminars in Oncology|January 14, 1998
Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancerC Bokemeyer, J T Hartmann, C S Lampe, et al.Anti-Cancer Drugs|July 11, 1998
Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancerJ T Hartmann, A Harstrick, T Daikeler, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1996
Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parametersC Bokemeyer, M A Kuczyk, J Serth, et al.Pageof 32